Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients
Clinical trial NCT01994850 · COMPLETED
Trial details
- NCT number
- NCT01994850
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2017-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.